Fig. 1From: Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trialsMean (95% CI) serum K+ over time. CI, confidence interval; K+, potassium. *p ≤ 0.001; †p < 0.01; ‡p < 0.05 for absolute change from baselineBack to article page